Fungicidal Mixtures Based on Azolopyrimidinylamines

A composition comprising

• a liquid or solid carrier;
• and
• a mixture of
• 1) an azolopyrimidinylamine of formula I
• wherein:
• R1 is C3-C12-alkyl, C2-C12-alkenyl, C5-C12-alkoxyalkyl, C3-C6-cycloalkyl, phenyl or phenyl-C1-C4-alkyl;
• R2 is C1-C12-alkyl, C2-C12-alkenyl, C1-C4-haloalkyl, C1-C4-alkoxy-C1-C4-alkyl;
• where the aliphatic chains in R1 and/or R2 may be substituted by one to four identical or different groups Ra:
• Ra is halogen, cyano, hydroxyl, mercapto, C1-C10-alkyl, C1-C10-haloalkyl, C3-C8-cycloalkyl, C2-C10-alkenyl, C2-C10-alkynyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C6-alkoxy-C1-C6-alkyl or NRARB;
• RA, RB are hydrogen and C1-C6-alkyl;
• where the cyclic groups in R1 and/or Ra may be substituted by one to four groups Rb:
• Rb is halogen, cyano, hydroxyl, mercapto, nitro, NRARB, C1-C10-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl or C1-C6-alkoxy;
• R3 is hydrogen, halogen, cyano, NRARB, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-alkylthio, C3-C8-cycloalkoxy, C3-C8-cycloalkylthio, carboxyl, formyl, C1-C10-alkylcarbonyl, C1-C10-alkoxycarbonyl, C2-C10-alkenyloxycarbonyl, C2-C10-alkynyloxycarbonyl, phenyl, phenoxy, phenylthio, benzyloxy, benzylthio, or C1-C6-alkyl-S(O)m—;
• m is 0, 1 or 2;
• A is CR3 or N;
• and
• 2) at least one active compound II selected from the group consisting of:
• A) bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, enilconazole, epoxiconazole, fluquinconazole, fenbuconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, simeconazole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, prochloraz, pefurazoate, imazalil, triflumizole, cyazofamid, benomyl, carbendazim, thiabendazole, fuberidazole, ethaboxam, etridiazole, hymexazole;
• B) azoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, trifloxystrobin, methyl (2-chloro-5-[1-(3-methylbenzyloxyimino)ethyl]benzyl)carbamate, methyl (2-chloro-5-[1-(6-methylpyridin-2-ylmethoxyimino)ethyl]benzyl)carbamate, methyl 2-(ortho-((2,5-dimethylphenyloxymethylene)phenyl)-3-methoxyacrylate;
• C) carboxin, benalaxyl, boscalid, fenhexamid, flutolanil, furametpyr, mepronil, metalaxyl, mefenoxam, ofurace, oxadixyl, oxycarboxin, penthiopyrad, thifluzamide, tiadinil, N-(4′-bromobiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(4′-trifluoromethylbiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(4′-chloro-3′-fluorobiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(3′,4′-dichloro-4-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide, N-(3′,4′-dichloro-5-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide, 3,4-dichloro-N-(2-cyanophenyl)isothiazol-5-carboxamide, dimethomorph, flumorph;
• flumetover, fluopicolide (picobenzamid), zoxamide, carpropamid, diclocymet, mandipropamid;
• N-(2-{4-[3-(4-chlorophenyl)prop-2-ynyloxy]-3-methoxyphenyl}ethyl)-2-methanesulfonylamino-3-methylbutyramide, N-(2-{4-[3-(4-chlorophenyl)-prop-2-ynyloxy]-3-methoxyphenyl}ethyl)-2-ethanesulfonylamino-3-methylbutyramide;
• D) fluazinam, pyrifenox, bupirimate, cyprodinil, fenarimol, ferimzone, mepanipyrim, nuarimol, pyrimethanil triforine, fenpiclonil, fludioxonil aldimorph, dodemorph, fenpropimorph, tridemorph, fenpropidin, iprodione, procymidone, vinclozolin, famoxadone, fenamidone, octhilinone, probenazole, anilazine, diclomezine, pyroquilon, proquinazid, tricyclazole, amisulbrom, 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine, 2-butoxy-6-iodo-3-propylchromen-4-one, acibenzolar-5-methyl, captafol, captan, dazomet, folpet, fenoxanil, quinoxyfen, 3-[5-(4-chlorophenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine;
• E) mancozeb, maneb, metam, metiram, ferbam, propineb, thiram, zineb, ziram, diethofencarb, iprovalicarb, flubenthiavalicarb, propamocarb, and methyl 3-(4-chlorophenyl)-3-(2-isopropoxycarbonylamino-3-methylbutyrylamino)propanoate;
• and
• F) dodine, iminoctadine, guazatine;
• kasugamycin, streptomycin, polyoxine, validamycin A;
• binapacryl, dinocap, dinobuton;
• dithianon, isoprothiolane;
• fentin salts;
• edifenphos, iprobenfos, fosetyl, fosetyl-aluminum, phosphorous acid and its salts, pyrazophos, tolclofos-methyl;
• chlorothalonil, dichlofluanid, flusulfamide, hexachlorobenzene, phthalide, pencycuron, quintozene, thiophanate-methyl, tolylfluanid;
• Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
• cyflufenamid, cymoxanil, dimethirimol, ethirimol, furalaxyl, metrafenone, spiroxamine;
• prohexadione and its salts, trinexapac-ethyl, chlormequat, mepiquat-chloride, diflufenzopyr;
• wherein the azolopyrimidinylamine of formula I and the at least one active compound II of the mixture are present in a synergistically effective amount.

A method for controlling phytopathogenic harmful fungi comprising

• treating fungi, their habitat, or plants to be protected against fungal attack, soil or seed with an effective amount of
• 1) an azolopyrimidinylamine of formula I
• wherein:
• R1 is C3-C12-alkyl, C2-C12-alkenyl, C5-C12-alkoxyalkyl, C3-C6-cycloalkyl, phenyl or phenyl-C1-C4-alkyl;
• R2 is C1-C12-alkyl, C2-C12-alkenyl, C1-C4-haloalkyl, C1-C4-alkoxy-C1-C4-alkyl;
• where the aliphatic chains in R1 and/or R2 may be substituted by one to four identical or different groups Ra:
• Ra is halogen, cyano, hydroxyl, mercapto, C1-C10-alkyl, C1-C10-haloalkyl, C3-C8-cycloalkyl, C2-C10-alkenyl, C2-C10-alkynyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C6-alkoxy-C1-C6-alkyl or NRARB;
• RA, RB are hydrogen and C1-C6-alkyl;
• where the cyclic groups in R1 and/or Ra may be substituted by one to four groups Rb:
• Rb is halogen, cyano, hydroxyl, mercapto, nitro, NRARB, C1-C10-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl or C1-C6-alkoxy;
• R3 is hydrogen, halogen, cyano, NRARB, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-alkylthio, C3-C8-cycloalkoxy, C3-C8-cycloalkylthio, carboxyl, formyl, C1-C10-alkylcarbonyl, C1-C10-alkoxycarbonyl, C2-C10-alkenyloxycarbonyl, C2-C10-alkynyloxycarbonyl, phenyl, phenoxy, phenylthio, benzyloxy, benzylthio, or C1-C6-alkyl-S(O)m—;
• m is 0, 1 or 2;
• A is CR3 or N;
• and
• 2) at least one active compound II selected from the group consisting of:
• A) bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, enilconazole, epoxiconazole, fluquinconazole, fenbuconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, simeconazole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, prochloraz, pefurazoate, imazalil, triflumizole, cyazofamid, benomyl, carbendazim, thiabendazole, fuberidazole, ethaboxam, etridiazole, hymexazole;
• B) azoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, trifloxystrobin, methyl (2-chloro-5-[1-(3-methylbenzyloxyimino)ethyl]benzyl)carbamate, methyl (2-chloro-5-[1-(6-methylpyridin-2-ylmethoxyimino)ethyl]benzyl)carbamate, methyl 2-(ortho-((2,5-dimethylphenyloxymethylene)phenyl)-3-methoxyacrylate;
• C) carboxin, benalaxyl, boscalid, fenhexamid, flutolanil, furametpyr, mepronil, metalaxyl, mefenoxam, ofurace, oxadixyl, oxycarboxin, penthiopyrad, thifluzamide, tiadinil, N-(4′-bromobiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(4′-trifluoromethylbiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(4′-chloro-3′-fluorobiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(3′,4′-dichloro-4-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide, N-(3′,4′-dichloro-5-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide, 3,4-dichloro-N-(2-cyanophenyl)isothiazol-5-carboxamide, dimethomorph, flumorph;
• flumetover, fluopicolide (picobenzamid), zoxamide, carpropamid, diclocymet, mandipropamid;
• N-(2-{4-[3-(4-chlorophenyl)prop-2-ynyloxy]-3-methoxyphenyl}ethyl)-2-methanesulfonylamino-3-methylbutyramide, N-(2-{4-[3-(4-chlorophenyl)-prop-2-ynyloxy]-3-methoxyphenyl}ethyl)-2-ethanesulfonylamino-3-methylbutyramide;
• D) fluazinam, pyrifenox, bupirimate, cyprodinil, fenarimol, ferimzone, mepanipyrim, nuarimol, pyrimethanil triforine, fenpiclonil, fludioxonil aldimorph, dodemorph, fenpropimorph, tridemorph, fenpropidin, iprodione, procymidone, vinclozolin, famoxadone, fenamidone, octhilinone, probenazole, anilazine, diclomezine, pyroquilon, proquinazid, tricyclazole, amisulbrom, 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine, 2-butoxy-6-iodo-3-propylchromen-4-one, acibenzolar-5-methyl, captafol, captan, dazomet, folpet, fenoxanil, quinoxyfen, 3-[5-(4-chlorophenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine;
• E) mancozeb, maneb, metam, metiram, ferbam, propineb, thiram, zineb, ziram, diethofencarb, iprovalicarb, flubenthiavalicarb, propamocarb, and methyl 3-(4-chlorophenyl)-3-(2-isopropoxycarbonylamino-3-methylbutyrylamino)propanoate;
• and
• F) dodine, iminoctadine, guazatine;
• kasugamycin, streptomycin, polyoxine, validamycin A;
• binapacryl, dinocap, dinobuton;
• dithianon, isoprothiolane;
• fentin salts;
• edifenphos, iprobenfos, fosetyl, fosetyl-aluminum, phosphorous acid and its salts, pyrazophos, tolclofos-methyl;
• chlorothalonil, dichlofluanid, flusulfamide, hexachlorobenzene, phthalide, pencycuron, quintozene, thiophanate-methyl, tolylfluanid;
• Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
• cyflufenamid, cymoxanil, dimethirimol, ethirimol, furalaxyl, metrafenone, spiroxamine;
• prohexadione and its salts, trinexapac-ethyl, chlormequat, mepiquat-chloride, diflufenzopyr;
• wherein the azolopyrimidinylamine of formula I and the at least one active compound II of the mixture are present in a synergistically effective amount;
• wherein the phytopathogenic harmful fungi are controlled.

Seed, comprising a mixture of

• 1) an azolopyrimidinylamine of formula I
• wherein:
• R1 is C3-C12-alkyl, C2-C12-alkenyl, C5-C12-alkoxyalkyl, C3-C6-cycloalkyl, phenyl or phenyl-C1-C4-alkyl;
• R2 is C1-C12-alkyl, C2-C12-alkenyl, C1-C4-haloalkyl, C1-C4-alkoxy-C1-C4-alkyl;
• where the aliphatic chains in R1 and/or R2 may be substituted by one to four identical or different groups Ra:
• Ra is halogen, cyano, hydroxyl, mercapto, C1-C10-alkyl, C1-C10-haloalkyl, C3-C8-cycloalkyl, C2-C10-alkenyl, C2-C10-alkynyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C6-alkoxy-C1-C6-alkyl or NRARB;
• RA, RB are hydrogen and C1-C6-alkyl;
• where the cyclic groups in R1 and/or Ra may be substituted by one to four groups Rb:
• Rb is halogen, cyano, hydroxyl, mercapto, nitro, NRARB, C1-C10-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl or C1-C6-alkoxy;
• R3 is hydrogen, halogen, cyano, NRARB, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-alkylthio, C3-C8-cycloalkoxy, C3-C8-cycloalkylthio, carboxyl, formyl, C1-C10-alkylcarbonyl, C1-C10-alkoxycarbonyl, C2-C10-alkenyloxycarbonyl, C2-C10-alkynyloxycarbonyl, phenyl, phenoxy, phenylthio, benzyloxy, benzylthio, or C1-C6-alkyl-S(O)m—;
• m is 0, 1 or 2;
• A is CR3 or N;
• and
• 2) at least one active compound II selected from the group consisting of:
• A) bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, enilconazole, epoxiconazole, fluquinconazole, fenbuconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, simeconazole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, prochloraz, pefurazoate, imazalil, triflumizole, cyazofamid, benomyl, carbendazim, thiabendazole, fuberidazole, ethaboxam, etridiazole, hymexazole;
• B) azoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, trifloxystrobin, methyl (2-chloro-5-[1-(3-methylbenzyloxyimino)ethyl]benzyl)carbamate, methyl (2-chloro-5-[1-(6-methylpyridin-2-ylmethoxyimino)ethyl]benzyl)carbamate, methyl 2-(ortho-((2,5-dimethylphenyloxymethylene)phenyl)-3-methoxyacrylate;
• C) carboxin, benalaxyl, boscalid, fenhexamid, flutolanil, furametpyr, mepronil, metalaxyl, mefenoxam, ofurace, oxadixyl, oxycarboxin, penthiopyrad, thifluzamide, tiadinil, N-(4′-bromobiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(4′-trifluoromethylbiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(4′-chloro-3′-fluorobiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(3′,4′-dichloro-4-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide, N-(3′,4′-dichloro-5-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide, 3,4-dichloro-N-(2-cyanophenyl)isothiazol-5-carboxamide, dimethomorph, flumorph;
• flumetover, fluopicolide (picobenzamid), zoxamide, carpropamid, diclocymet, mandipropamid;
• N-(2-{4-[3-(4-chlorophenyl)prop-2-ynyloxy]-3-methoxyphenyl}ethyl)-2-methanesulfonylamino-3-methylbutyramide, N-(2-{4-[3-(4-chlorophenyl)-prop-2-ynyloxy]-3-methoxyphenyl}ethyl)-2-ethanesulfonylamino-3-methylbutyramide;
• D) fluazinam, pyrifenox, bupirimate, cyprodinil, fenarimol, ferimzone, mepanipyrim, nuarimol, pyrimethanil triforine, fenpiclonil, fludioxonil aldimorph, dodemorph, fenpropimorph, tridemorph, fenpropidin, iprodione, procymidone, vinclozolin, famoxadone, fenamidone, octhilinone, probenazole, anilazine, diclomezine, pyroquilon, proquinazid, tricyclazole, amisulbrom, 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine, 2-butoxy-6-iodo-3-propylchromen-4-one, acibenzolar-5-methyl, captafol, captan, dazomet, folpet, fenoxanil, quinoxyfen, 3-[5-(4-chlorophenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine;
• E) mancozeb, maneb, metam, metiram, ferbam, propineb, thiram, zineb, ziram, diethofencarb, iprovalicarb, flubenthiavalicarb, propamocarb, and methyl 3-(4-chlorophenyl)-3-(2-isopropoxycarbonylamino-3-methylbutyrylamino)propanoate;
• and
• F) dodine, iminoctadine, guazatine;
• kasugamycin, streptomycin, polyoxine, validamycin A;
• binapacryl, dinocap, dinobuton;
• dithianon, isoprothiolane;
• fentin salts;
• edifenphos, iprobenfos, fosetyl, fosetyl-aluminum, phosphorous acid and its salts, pyrazophos, tolclofos-methyl;
• chlorothalonil, dichlofluanid, flusulfamide, hexachlorobenzene, phthalide, pencycuron, quintozene, thiophanate-methyl, tolylfluanid;
• Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
• cyflufenamid, cymoxanil, dimethirimol, ethirimol, furalaxyl, metrafenone, spiroxamine;
• prohexadione and its salts, trinexapac-ethyl, chlormequat, mepiquat-chloride, diflufenzopyr;
• wherein the azolopyrimidinylamine of formula I and the at least one active compound II of the mixture are present in a synergistically effective amount;
• in an amount of from 1 to 1000 g/100 kg of seed.

A process for preparing a composition comprising

• contacting liquid or solid carriers with a mixture of
• 1) an azolopyrimidinylamine of formula I
• wherein:
• R1 is C3-C12-alkyl, C2-C12-alkenyl, C5-C12-alkoxyalkyl, C3-C6-cycloalkyl, phenyl or phenyl-C1-C4-alkyl;
• R2 is C1-C12-alkyl, C2-C12-alkenyl, C1-C4-haloalkyl, C1-C4-alkoxy-C1-C4-alkyl;
• where the aliphatic chains in R1 and/or R2 may be substituted by one to four identical or different groups Ra:
• Ra is halogen, cyano, hydroxyl, mercapto, C1-C10-alkyl, C1-C10-haloalkyl, C3-C8-cycloalkyl, C2-C10-alkenyl, C2-C10-alkynyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C6-alkoxy-C1-C6-alkyl or NRARB;
• RA, RB are hydrogen and C1-C6-alkyl;
• where the cyclic groups in R1 and/or Ra may be substituted by one to four groups Rb:
• Rb is halogen, cyano, hydroxyl, mercapto, nitro, NRARB, C1-C10-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl or C1-C6-alkoxy;
• R3 is hydrogen, halogen, cyano, NRARB, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-alkylthio, C3-C8-cycloalkoxy, C3-C8-cycloalkylthio, carboxyl, formyl, C1-C10-alkylcarbonyl, C1-C10-alkoxycarbonyl, C2-C10-alkenyloxycarbonyl, C2-C10-alkynyloxycarbonyl, phenyl, phenoxy, phenylthio, benzyloxy, benzylthio, or C1-C6-alkyl-S(O)m—;
• m is 0, 1 or 2;
• A is CR3 or N;
• and
• 2) at least one active compound II selected from the group consisting of:
• A) bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, enilconazole, epoxiconazole, fluquinconazole, fenbuconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, simeconazole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, prochloraz, pefurazoate, imazalil, triflumizole, cyazofamid, benomyl, carbendazim, thiabendazole, fuberidazole, ethaboxam, etridiazole, hymexazole;
• B) azoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, trifloxystrobin, methyl (2-chloro-5-[1-(3-methylbenzyloxyimino)ethyl]benzyl)carbamate, methyl (2-chloro-5-[1-(6-methylpyridin-2-ylmethoxyimino)ethyl]benzyl)carbamate, methyl 2-(ortho-((2,5-dimethylphenyloxymethylene)phenyl)-3-methoxyacrylate;
• C) carboxin, benalaxyl, boscalid, fenhexamid, flutolanil, furametpyr, mepronil, metalaxyl, mefenoxam, ofurace, oxadixyl, oxycarboxin, penthiopyrad, thifluzamide, tiadinil, N-(4′-bromobiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(4′-trifluoromethylbiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(4′-chloro-3′-fluorobiphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-carboxamide, N-(3′,4′-dichloro-4-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide, N-(3′,4′-dichloro-5-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-carboxamide, 3,4-dichloro-N-(2-cyanophenyl)isothiazol-5-carboxamide, dimethomorph, flumorph;
• flumetover, fluopicolide (picobenzamid), zoxamide, carpropamid, diclocymet, mandipropamid;
• N-(2-{4-[3-(4-chlorophenyl)prop-2-ynyloxy]-3-methoxyphenyl}ethyl)-2-methanesulfonylamino-3-methylbutyramide, N-(2-{4-[3-(4-chlorophenyl)-prop-2-ynyloxy]-3-methoxyphenyl}ethyl)-2-ethanesulfonylamino-3-methylbutyramide;
• D) fluazinam, pyrifenox, bupirimate, cyprodinil, fenarimol, ferimzone, mepanipyrim, nuarimol, pyrimethanil triforine, fenpiclonil, fludioxonil aldimorph, dodemorph, fenpropimorph, tridemorph, fenpropidin, iprodione, procymidone, vinclozolin, famoxadone, fenamidone, octhilinone, probenazole, anilazine, diclomezine, pyroquilon, proquinazid, tricyclazole, amisulbrom, 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine, 2-butoxy-6-iodo-3-propylchromen-4-one, acibenzolar-5-methyl, captafol, captan, dazomet, folpet, fenoxanil, quinoxyfen, 3-[5-(4-chlorophenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine;
• E) mancozeb, maneb, metam, metiram, ferbam, propineb, thiram, zineb, ziram, diethofencarb, iprovalicarb, flubenthiavalicarb, propamocarb, and methyl 3-(4-chlorophenyl)-3-(2-isopropoxycarbonylamino-3-methylbutyrylamino)propanoate;
• and
• F) dodine, iminoctadine, guazatine;
• kasugamycin, streptomycin, polyoxine, validamycin A;
• binapacryl, dinocap, dinobuton;
• dithianon, isoprothiolane;
• fentin salts;
• edifenphos, iprobenfos, fosetyl, fosetyl-aluminum, phosphorous acid and its salts, pyrazophos, tolclofos-methyl;
• chlorothalonil, dichlofluanid, flusulfamide, hexachlorobenzene, phthalide, pencycuron, quintozene, thiophanate-methyl, tolylfluanid;
• Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
• cyflufenamid, cymoxanil, dimethirimol, ethirimol, furalaxyl, metrafenone, spiroxamine;
• prohexadione and its salts, trinexapac-ethyl, chlormequat, mepiquat-chloride, diflufenzopyr;
• wherein the azolopyrimidinylamine of formula I and the at least one active compound II of the mixture are present in a synergistically effective amount;
• wherein a composition is prepared.